CLIA Mycoplasma
Chemiluminescence kit for the detection of IgG, IgA or IgM antibodies to Mycolasma pneumoniae
in human serum or plasma
in human serum or plasma
Mycoplasma pneumoniae is a primary pathogenic agent of the human respiratory tract. It causes a disease that has been described as primary atypical pneumonia accompanied by fever, nausea, ague, cough, and fatigue. M pneumoniae accounts for approximately 20 % of all cases of pneumonia. The disease is well curable with antibiotics. The pathogen is airborne, spread especially in children’s groups with typical spring and autumn seasons.
Products
Advantages
- Detection of IgG, IgA or IgM antibodies to Mycoplasma pneumoniae
- Screen for recent or past exposure to M. pneumoniae
- Intended for human serum and citrate plasma
- Purified and inactivated antigen of M. pneumoniae enriched with highly specific immunodominant epitopes used
- The kits are CE-IVD certified and intended for professional use
- For each CLIA kit a corresponding control set is available
| Assay time | 30 min. |
| Assay stability | 30 days in-board-stability / in-use-stability until the expiration date at storage temperature 2-8 °C |
| Sample matrix | Serum, Plasma |
| Measuring range | 0.5 - 320 U/ml (IgG), 0.1 - 320 U/ml (IgA), 2 - 160 U/ml (IgM) |
| Sample volume | 10 µl |
| Assay/kit content | Reagent Cartridge with specific reagents for the assay, magnetic particles, calibrators |